| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |